Tianshui Zhongxing Bio-technology Co.,Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 1,059.1 million compared to CNY 1,033.84 million a year ago. Revenue was CNY 1,059.1 million compared to CNY 1,033.84 million a year ago. Net loss was CNY 49 million compared to net income of CNY 120.67 million a year ago. Basic loss per share from continuing operations was CNY 0.1356 compared to basic earnings per share from continuing operations of CNY 0.354 a year ago. Diluted loss per share from continuing operations was CNY 0.1356 compared to diluted earnings per share from continuing operations of CNY 0.354 a year ago.